Search results for "Enos"

showing 10 items of 1576 documents

Liver-specific methionine adenosyltransferase MAT1A gene expression is associated with a specific pattern of promoter methylation and histone acetyla…

2000

Methionine adenosyltransferase (MAT) is the enzyme that catalyzes the synthesis of S-adenosylmethionine (AdoMet), the main donor of methyl groups in the cell. In mammals MAT is the product of two genes, MAT1A and MAT2A. MAT1A is expressed only in the mature liver whereas fetal hepatocytes, extrahepatic tissues and liver cancer cells express MAT2A. The mechanisms behind the tissue and differentiation state specific MAT1A expression are not known. In the present work we examined MAT1A promoter methylation status by means of methylation sensitive restriction enzyme analysis. Our data indicate that MAT1A promoter is hypomethylated in liver and hypermethylated in kidney and fetal rat hepatocytes…

Malemedicine.drug_classBiologyBiochemistryGene Expression Regulation EnzymologicHistonesGeneticsmedicineAnimalsGene SilencingRats WistarPromoter Regions GeneticMolecular BiologyRegulation of gene expressionHistone deacetylase inhibitorNucleic Acid HybridizationAcetylationMethylationMethionine AdenosyltransferaseDNA MethylationMolecular biologyChromatinRatsHistoneLiverAcetylationHistone methyltransferaseDNA methylationCancer researchbiology.proteinBiotechnologyFASEB journal : official publication of the Federation of American Societies for Experimental Biology
researchProduct

Rationale and design of the Prospective LongitudinAl Trial of FFRCT: Outcome and Resource IMpacts study

2015

International audience; BACKGROUND: Fractional flow reserve (FFR) measured by coronary computed tomography angiography (FFRCT) has been validated against invasive FFR. However, there are no data on how the use of FFRCT affects patient care and outcomes. The aim of this study is to compare standard practice guided by usual care testing to FFRCT-guided management in symptomatic subjects with suspected coronary artery disease (CAD). METHODS: In this prospective nonrandomized trial, symptomatic patients with suspected CAD will be enrolled in 2 consecutive cohorts: a usual care-guided pathway (cohort 1) and an FFRCT-guided pathway (cohort 2). Each cohort is divided into 2 groups according to whe…

Malemedicine.medical_specialty*Tomography[SDV]Life Sciences [q-bio]Fractional flow reserveCoronary Artery DiseaseCoronary AngiographyCoronary Angiography/*methodsCoronary artery diseaseCoronary Artery Disease/*diagnosis/physiopathologyQuality of lifeRandomized Controlled Trials as Topic/*methodsPredictive Value of TestsMyocardial/*physiologyOutcome Assessment Health CareClinical endpointMedicineHumansProspective StudiesProspective cohort studyRandomized Controlled Trials as TopicAgedbusiness.industryMiddle Agedmedicine.diseaseFractional Flow Reserve3. Good healthX-Ray ComputedFractional Flow Reserve MyocardialStenosisPredictive value of testsCohortFemaleRadiologyOutcome Assessment (Health Care)/*methodsCardiology and Cardiovascular MedicinebusinessTomography X-Ray ComputedFollow-Up Studies
researchProduct

To assess hemodynamic disturbances to the ostia of the renal arteries generated by the implantation of EVAR with a suprarenal fixation

2020

Abstract Introduction: The treatment of abdominal aortic aneurysm (AAA) is increasingly performed via endovascular aneurysm repair (EVAR). Different types of fixation are possible with EVAR, i.e., below (infrarenal fixation) or above (suprarenal fixation) the renal arteries. Hemodynamic alterations in renal arterial flow with suprarenal (SR) fixation remain to be demonstrated. The IFIXEAR (Impact of Supra-renal Fixation of EVAR on Hemodynamics of Renal Arteries) study is designed to assess the hemodynamic effects at the ostia of at least 1 renal artery, generated immediately post-surgery by the implantation of an aortic stent with SR fixation. Methods: IFIXEAR is a prospective, 2 center stu…

Malemedicine.medical_specialty3400medicine.medical_treatmentaortic aneurysm abdominalHemodynamicsEndovascular aneurysm repair03 medical and health sciencesAortic aneurysm0302 clinical medicineRenal ArteryStudy Protocol Clinical Trialmedicine.arterymedicineClinical endpointHumans030212 general & internal medicineRenal arteryFixation (histology)renal artery stenosisbusiness.industryEndovascular ProceduresHemodynamicsGeneral Medicinemedicine.diseaseAbdominal aortic aneurysmSurgery030220 oncology & carcinogenesisFemalebusinessAbdominal surgeryResearch ArticleAortic Aneurysm AbdominalMedicine
researchProduct

Intrahepatic bile duct dilation and gallbladder hydrops due to a cystic duct stenosis in a 2-month-old boy.

2015

A 2-month-old boy presented with slight diffuse abdominal pain after an uncomplicated pregnancy and perinatal period. Height (62 cm) and weight (5.5 kg) were according to the age. Routine blood tests showed no abnormalities except for a minimal elevation of aspartate aminotransferase to 38 units/L (reference range 5–35 U/L). Primary abdominal ultrasound showed a dilation of the common bile duct and a gallbladder hydrops (figure 1). MR cholangiopancreatography (MRCP) was indicated to detect the cause for these incidental findings. Contrary to normal bile ducts in …

Malemedicine.medical_specialtyAbdominal painCholangiopancreatography Magnetic ResonanceGallbladder diseaseIntrahepatic bile ductsReference rangeConstriction PathologicGallbladder DiseasesGastroenterologyArticleDiagnosis DifferentialInternal medicinemedicineHumansCommon bile ductbusiness.industryGeneral surgeryCystic DuctInfantGeneral Medicinemedicine.diseaseStenosismedicine.anatomical_structureBile Ducts IntrahepaticCystic ductDifferential diagnosismedicine.symptombusinessDilatation PathologicBMJ case reports
researchProduct

Prognostic value of plasma tissue factor and tissue factor pathway inhibitor for cardiovascular death in patients with coronary artery disease: the A…

2007

Summary. Background: Tissue factor (TF) and its specific inhibitor, tissue factor pathway inhibitor (TFPI), are important contributors to the initiation of the coagulation process. Objectives: To compare plasma levels of soluble TF (sTF) and free-TFPI (f-TFPI) between patients with stable angina pectoris (SAP) and acute coronary syndrome (ACS) and to assess the impact of the two variables on long-term prognosis. Patients/methods: Patients with SAPs (n = 1146) and acute coronary syndrome (n = 523) from the AtheroGene study were included and followed for 2.3 years. Because of the strong impact of unfractionated heparin (UFH) on f-TFPI levels, but not on sTF levels, patients having received UF…

Malemedicine.medical_specialtyAcute coronary syndromeTime FactorsLipoproteinsMyocardial InfarctionRisk AssessmentSeverity of Illness IndexAngina PectorisThromboplastinCoronary artery diseaseCohort StudiesTissue factor pathway inhibitorPredictive Value of TestsInternal medicineGermanymedicineHumansMyocardial infarctionProspective StudiesAgedProportional Hazards ModelsUnstable anginabusiness.industryHazard ratioCoronary StenosisHematologySyndromeMiddle Agedmedicine.diseasePrognosisThrombosisCardiovascular DiseasesCardiologyFemalebusinessBiomarkersBlood drawingFollow-Up StudiesJournal of thrombosis and haemostasis : JTH
researchProduct

The glucocorticoid in acute decompensated heart failure: Dr Jekyll or Mr Hyde?

2012

Glucocorticoid administration is not recommended in patients with heart failure because of its related sodium and fluid retention. However, previous experimental and clinical studies have demonstrated that glucocorticoids can also induce a diuretic effect and improve renal function in patients with acute decompensated heart failure (ADHF) with refractory diuretic resistance. We report the case of a 65-year-old man with a known diagnosis of aortic stenosis, systolic ventricular dysfunction, and chronic obstructive pulmonary disease who was admitted for ADHF. After 3 days, during which resistance to conventional therapy was observed, intravenous methylprednisolone (60 mg/d) was added to ongoi…

Malemedicine.medical_specialtyAcute decompensated heart failuremedicine.medical_treatmentRenal functionMethylprednisoloneRefractoryInternal medicinemedicineHumansDiureticsGlucocorticoidsAgedHeart Failurebusiness.industryGeneral Medicinemedicine.diseaseBrain natriuretic peptideStenosisglucocorticoid. acute decompensated hert failureEndocrinologyHeart failureAcute DiseaseEmergency MedicineCardiologyDiureticbusinessGlucocorticoidmedicine.drug
researchProduct

Arrhythmia Termination Versus Elimination of Dormant Pulmonary Vein Conduction as a Procedural End Point of Catheter Ablation for Paroxysmal Atrial F…

2015

Background— Pulmonary vein isolation (PVI) is still associated with a substantial number of arrhythmia recurrences in paroxysmal atrial fibrillation (AF). This prospective, randomized study aimed to compare 2 different procedural strategies. Methods and Results— A total of 152 patients undergoing de novo ablation for paroxysmal AF were randomized to 2 different treatment arms. The procedure in group A consisted of PVI exclusively. In this group, all isolated PVs were challenged with adenosine to reveal and ablate dormant conduction. In group B, PVI was performed with the patient either in spontaneous or in induced AF. If AF did not terminate with PVI, ablation was continued by targeting ex…

Malemedicine.medical_specialtyAdenosine5Endpoint Determinationpulmonary veinsmedicine.medical_treatmentCatheter ablation22law.inventionPulmonary veinElectrocardiographyRandomized controlled triallawRecurrencePhysiology (medical)Internal medicineAtrial Fibrillationcatheter ablationmedicineHumansSinus rhythmProspective StudiesProspective cohort studyAgedmedicine.diagnostic_testbusiness.industryAtrial fibrillationOriginal ArticlesMiddle Agedarrhythmias cardiacmedicine.diseaseAblationfollow-up studiesTreatment OutcomeAnesthesiaCardiologyFemaleCardiology and Cardiovascular MedicinebusinessElectrocardiographyAnti-Arrhythmia AgentsCirculation. Arrhythmia and electrophysiology
researchProduct

Endogenous adenosine inhibits hippocampal CA1 neurones: further evidence from extra- and intracellular recording.

1988

Extracellular and intracellular recordings from CA1 pyramidal neurones of rats in vitro were used to study the effects of endogenous and exogenously applied adenosine. The adenosine receptor antagonist, caffeine, enhanced the intracellular recorded e.p.s.p.-i.p.s.p. sequence evoked by stimulation of the stratum radiatum which is antagonized by exogenous adenosine. The late, potassium dependent i.p.s.p. was not antagonized. The adenosine uptake inhibitor, nitrobenzylthioinosine (NBTI), mimicked the effects of exogenously applied adenosine. The effects of NBTI and of exogenously applied adenosine were antagonized by caffeine in the same manner. Exposure to adenosine deaminase enhanced the evo…

Malemedicine.medical_specialtyAdenosineAdenosine DeaminasePharmacologyIn Vitro TechniquesAdenosine receptor antagonistHippocampusAdenosine A1 receptorchemistry.chemical_compoundAdenosine deaminaseThioinosineInternal medicineCaffeinemedicineAnimalsEvoked PotentialsPharmacologyNeuronsbiologyChemistryRats Inbred StrainsGeneral MedicinePurinergic signallingAdenosineAdenosine receptorRatsElectrophysiologyEndocrinologybiology.proteinCaffeineIntracellularmedicine.drugNaunyn-Schmiedeberg's archives of pharmacology
researchProduct

Effects of alkylxanthines on contractility of diaphragm fibres isolated from normal and sensitized guinea-pigs.

1993

Abstract This study investigates the effects of alkylxanthines on twitch tension generated by electrical stimulation (supramaximal pulses, 0·2 ms duration, 1 Hz) of diaphragm muscle fibres isolated from normal and actively-sensitized guinea-pigs. Caffeine, theophylline and theobromine increased, in a concentration-dependent manner (50–500 μm), twitch tension in normal and sensitized diaphragm. Caffeine (500 μm) enhanced contractility to a greater extent than theophylline or theobromine. Twitch potentiation by caffeine (500 μm) was significantly greater in sensitized diaphragm. Verapamil (0·1–100 μm) did not alter twitch contractions in the absence or presence of alkylxanthines in normal or …

Malemedicine.medical_specialtyAdenosineDiaphragmGuinea PigsPharmaceutical ScienceIn Vitro TechniquesDantroleneDantroleneContractilitychemistry.chemical_compoundTheophyllineInternal medicineCaffeinemedicineAnimalsTheophyllineRespiratory systemRats WistarPharmacologyMuscle SmoothSerum Albumin Bovinemusculoskeletal systemElectric StimulationDiaphragm (structural system)Bronchodilator AgentsCulture MediaRatsEndocrinologychemistryVerapamilXanthinesEnprofyllineTheobromineCalciumFemaleImmunizationmedicine.symptomCaffeineExtracellular Spacemedicine.drugMuscle contractionMuscle ContractionThe Journal of pharmacy and pharmacology
researchProduct

The specificity of prostaglandin E2 (PGE2) in reducing coronary vascular resistance: A comparison with adenosine.

1978

Experiments were performed on the isolated, electrically driven guinea-pig heart, perfused at constant rate. All animals were pretreated with reserpine. Myocardial contractile force (MCF), coronary perfusion pressure (CPP) and myocardial oxygen consumption (QO2) were monitored continuously. Both adenosine (ADO) and PGE2 produced a concentration-dependent decrease in the CPP. The ED50 (50% of maximum response) was 2.1 +/- 0.6 X 10(-9)M for PGE2 but 40 +/- 7 X 10(-9)M for ADO (P less than 0.01) at 1.8 mM Ca(e). This coronary vasodilation was independent of the external Ca-concentration, which was varied between 0.55-9.0 mM. PGE2 had no effect on MCF or QO2 and the effect of ADO was only sligh…

Malemedicine.medical_specialtyAdenosinePhysiologyGuinea Pigschemistry.chemical_elementProstaglandinBlood PressureOxygenchemistry.chemical_compoundOxygen ConsumptionPhysiology (medical)Internal medicinemedicineAnimalsProstaglandin E2Prostaglandins EReserpineAdenosineCoronary VesselsPerfusionConstant ratemedicine.anatomical_structurechemistryCardiologyCoronary perfusion pressureVascular resistanceFemaleVascular ResistanceCardiology and Cardiovascular Medicinemedicine.drugBasic research in cardiology
researchProduct